A hierarchically selective immunotherapeutic nanoplatform, mGls@HEV‐MTP, selectively restores macrophage immunocompetence through GLS1‐mediated restoration of glutaminolysis‐fueled anaplerosis. Concurrently, it renders Staphylococcus aureus (S. aureus) more readily recognizable to the metabolically reprogrammed macrophages, thereby facilitating ...
Weinan Yang +17 more
wiley +1 more source
Oritavancin safety: a real-world pharmacovigilance study of the FAERS database. [PDF]
Xie B, Zhou YF, Song HC, Cui XJ.
europepmc +1 more source
Macrophage Trogocytosis of Tumor Cells Drives the Immunosuppression of Tumor Microenvironment
Trogocytosis efficiency varies significantly among different tumor cells and is inversely related to their cortical stiffness; this efficiency dictates the extent of immunosuppression via upregulation of CXCL5 and Arg‐1, ultimately driving CD8+T cell exhaustion and tumor escape.
Chao Liang +9 more
wiley +1 more source
Safety signals of tocilizumab in pediatric patients: A real-world pharmacovigilance analysis based on the FAERS database with network pharmacology insights. [PDF]
Wu G, Ma X, Zhu B, Liu B.
europepmc +1 more source
Consumers' experiences and perspectives on reporting adverse drug reactions using digital tools: a qualitative study. [PDF]
Dedefo MG +5 more
europepmc +1 more source
When does Follow-up on Adverse Events Improve the Understanding of Medicine and Vaccine Safety? Insights from Global Expert Perspectives. [PDF]
Kara V +5 more
europepmc +1 more source
Comparative Reporting Patterns of Rabeprazole and Other Proton Pump Inhibitors in EudraVigilance: A System Organ Class-Level Disproportionality Analysis. [PDF]
Moleriu RD +6 more
europepmc +1 more source
Fifteen-year real-world pharmacovigilance of multiple sclerosis disease-modifying therapies: adverse event profiles, drug-specific safety signals and clinical implications. [PDF]
Lin S +6 more
europepmc +1 more source
Machine learning-assisted mRNA vaccine pharmacovigilance: a systematic review of multi-source real-world data. [PDF]
He Y, Mao Y, Wang X.
europepmc +1 more source

